Less stress, more success? Oncological implications of surgery-induced oxidative stress

Abstract

Reactive oxygen species (ROS) possess important cell signalling properties. This contradicts traditional thought which associated ROS activity with cell death. Emerging evidence clearly demonstrates that ROS signalling acts as a key regulator in tumour cell survival and in the cellular processes required for tumour cells to successfully metastasise and proliferate. The discovery of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) family of enzymes in the last decade has unravelled much of the mystery surrounding how ROS are generated. Tumour cells are now known to express Nox enzymes which produce ROS required for cellular signalling. Activation of Nox enzymes occurs via interaction with proinflammatory cytokines and growth factors, all of which are released following surgical trauma. As our understanding of the signalling capabilities of ROS grows, the oncological implications of ROS activity are gradually being revealed. Nox-derived ROS are known to play a central role in each step of the metastatic cascade including invasion, adhesion, angiogenesis and proliferation. This article describes how surgery creates a ROS-rich environment, which facilitates redox signalling, and also examines the role played by Nox enzymes in this process. The authors then explore current knowledge of the oncological implications of surgery-induced redox signalling, and discuss current and future therapeutic strategies targeted at ROS and Nox enzymes in cancer patients.

Influence of complications following immediate breast reconstruction on breast cancer recurrence rates

“…There is strong evidence of survival implications for patients who develop postoperative complications, including wound infection, in other forms of cancer. In colonic cancer, for example, anastomotic leaks, with resulting peritoneal infection, affect survival.…”

Oxidative stress and angiogenesis in primary hyperparathyroidism

“…We could suspect that the surgery could cause the changes in oxidative status; however, the surgery itself is a widely known factor triggering ROS production [45, 46]. What is more, surgical trauma is responsible for metastasis development and promotion of tumor growth postoperatively, and this complication is related to ROS-rich environment in the postoperative period [47, 48]. On the other hand, Kaçmaz et al.…”

Sequence analysis of the E-cadherin (CDH1) gene in a cohort of gastric cancers seen in the western cape

“…The consequence is cell accumulation, loss of tissue differentiation, loss of cellular adhesion, nuclear enlargement, enhanced mitotic activity and eventually metastasis (Coup et al, 2004;O'Leary et al, 2011). Cancer cells can invade the blood vessels and metastasise to various organs in the body.…”